FDA Approved: DEXTROAMPHETAMINE SULFATE — Supplemental Application (Aurolife Pharma, LLC)

View source ↗

Summary

FDA approves a supplemental application for a generic form of dextroamphetamine sulfate by Aurolife Pharma, enabling its market authorization.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Narcolepsy

Drugs mentioned

• Dextroamphetamine sulfate (dextroamphetamine sulfate)

Snippet

SUPPL AP for DEXTROAMPHETAMINE SULFATE (DEXTROAMPHETAMINE SULFATE)